skip to main content
Mostrar Somente
Refinado por: Base de dados/Biblioteca: Lippincott Williams & Wilkins remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A first-in-human phase Ib study to evaluate the MEK inhibitor GDC-0973, combined with the pan-PI3K inhibitor GDC-0941, in patients with advanced solid tumors
Material Type:
Artigo
Adicionar ao Meu Espaço

A first-in-human phase Ib study to evaluate the MEK inhibitor GDC-0973, combined with the pan-PI3K inhibitor GDC-0941, in patients with advanced solid tumors

LoRusso, Patricia ; Shapiro, Geoffrey ; Pandya, Shuchi Sumant ; Kwak, Eunice Lee ; Jones, Cheryl ; Belvin, Marcia ; Musib, Luna C. ; de Crespigny, Alex ; McKenzie, Meghan ; Gates, Mary R. ; Chan, Iris Tan-Chi ; Bendell, Johanna C.

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.2566-2566 [Periódico revisado por pares]

Texto completo disponível

2
Attitudes of physician faculty members and residents toward the pregnant medical resident
Material Type:
Artigo
Adicionar ao Meu Espaço

Attitudes of physician faculty members and residents toward the pregnant medical resident

Shapiro, J

Academic medicine, 1982-06, Vol.57 (6), p.483-6 [Periódico revisado por pares]

United States

Texto completo disponível

3
Becoming a physician: students' creative projects in a third-year IM clerkship
Material Type:
Artigo
Adicionar ao Meu Espaço

Becoming a physician: students' creative projects in a third-year IM clerkship

Rucker, Lloyd ; Shapiro, Johanna

Academic medicine, 2003-04, Vol.78 (4), p.391-397 [Periódico revisado por pares]

United States

Texto completo disponível

4
BT5528-100 phase I/II study of the safety, pharmacokinetics, and preliminary clinical activity of BT5528 in patients with advanced malignancies associated with EphA2 expression
Material Type:
Artigo
Adicionar ao Meu Espaço

BT5528-100 phase I/II study of the safety, pharmacokinetics, and preliminary clinical activity of BT5528 in patients with advanced malignancies associated with EphA2 expression

Bendell, Johanna C. ; Wang, Judy Sing-Zan ; Bashir, Babar ; Richardson, Debra L. ; Bennett, Gavin ; Campbell, Carly ; Hennessy, Meliessa G. ; Jeffrey, Phil ; Kirui, Julius ; Mahnke, Lisa ; Shapiro, Geoffrey

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS3655-TPS3655 [Periódico revisado por pares]

Texto completo disponível

5
Can poetry make better doctors? Teaching the humanities and arts to medical students and residents at the University of California, Irvine, College of Medicine
Material Type:
Artigo
Adicionar ao Meu Espaço

Can poetry make better doctors? Teaching the humanities and arts to medical students and residents at the University of California, Irvine, College of Medicine

Shapiro, Johanna ; Rucker, Lloyd

Academic medicine, 2003-10, Vol.78 (10), p.953-957 [Periódico revisado por pares]

United States

Texto completo disponível

6
CB-839, a glutaminase inhibitor, in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer (mRCC): Results of a phase I study
Material Type:
Artigo
Adicionar ao Meu Espaço

CB-839, a glutaminase inhibitor, in combination with cabozantinib in patients with clear cell and papillary metastatic renal cell cancer (mRCC): Results of a phase I study

Meric-Bernstam, Funda ; Lee, Richard J. ; Carthon, Bradley Curtis ; Iliopoulos, Othon ; Mier, James Walter ; Patel, Manish R. ; Tannir, Nizar M. ; Owonikoko, Taofeek Kunle ; Haas, Naomi B. ; Voss, Martin Henner ; Harding, James J. ; Srinivasan, Ramaprasad ; Shapiro, Geoffrey ; Telli, Melinda L. ; Munster, Pamela N. ; Carvajal, Richard D. ; Jenkins, Yonchu ; Whiting, Sam H. ; Bendell, Johanna C. ; Bauer, Todd Michael

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.549-549 [Periódico revisado por pares]

Texto completo disponível

7
Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Combination of a MEK inhibitor, pimasertib (MSC1936369B), and a PI3K/mTOR inhibitor, SAR245409, in patients with advanced solid tumors: Results of a phase Ib dose-escalation trial

Heist, Rebecca Suk ; Gandhi, Leena ; Shapiro, Geoffrey ; Rizvi, Naiyer A. ; Burris, Howard A. ; Bendell, Johanna C. ; Baselga, Jose ; Yerganian, Scott B ; Hsu, Karl ; Ogden, Janet ; Vincent, Loïc ; Richter, Oliver von ; Locatelli, Giuseppe ; Asatiani, Ekatherine ; Infante, Jeffrey R.

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.2530-2530 [Periódico revisado por pares]

Texto completo disponível

8
Commentary
Material Type:
Artigo
Adicionar ao Meu Espaço

Commentary

Shapiro, Johanna

Academic medicine, 2012-11, Vol.87 (11), p.1571 [Periódico revisado por pares]

Texto completo disponível

9
Commentary
Material Type:
Artigo
Adicionar ao Meu Espaço

Commentary

Shapiro, Johanna

Academic medicine, 2005-10, Vol.80 (10), p.909 [Periódico revisado por pares]

Texto completo disponível

10
Commentary
Material Type:
Artigo
Adicionar ao Meu Espaço

Commentary

Shapiro, Johanna

Academic medicine, 2009-03, Vol.84 (3), p.355 [Periódico revisado por pares]

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (41)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (42)
  2. Resenhas  (1)
  3. Mais opções open sub menu

Data de Publicação 

De até
  1. Antes de2000  (4)
  2. 2000Até2004  (12)
  3. 2005Até2011  (10)
  4. 2012Até2016  (11)
  5. Após 2016  (7)
  6. Mais opções open sub menu

Buscando em bases de dados remotas. Favor aguardar.